|
Catherine Saez and William New reporting in Intellectual Property Watch: “New generic top-level domain names seem set to be a constant source of discussions and dissension. The domain ‘.pharmacy’ has been awarded to a United States pharmacy association with industry backing, stirring concerns among civil society and others. But the association insists it will work in an impartial manner to ensure safety of online pharmaceutical sales… The pharmacy gTLD is expected to be launched by NABP by autumn 2014. However, according to Gabriel Levitt, vice-president of the company PharmacyChecker.com, the main funders of the NABP application are Eli Lily, Merck and Pfizer, as shown on NABP ‘coalition support’ web page.”
Sponsored byVerisign
Sponsored byCSC
Sponsored byIPv4.Global
Sponsored byRadix
Sponsored byVerisign
Sponsored byDNIB.com
Sponsored byWhoisXML API